Where Does Catalent Inc (CTLT) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Has Fallen -0.64% This Week?

Catalent Inc (CTLT) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. CTLT received an overall rating of 51, which means that it scores higher than 51 percent of all stocks. Catalent Inc also achieved a score of 71 in the Drug Manufacturers - Specialty & Generic industry, putting it above 71 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 102 out of the 148 industries.

CTLT has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on CTLT!

See Full CTLT Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 51 would rank higher than 51 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Catalent Inc Stock Today?

Catalent Inc (CTLT) stock is higher by 0.02% while the S&P 500 is lower by -0.04% as of 3:37 PM on Friday, Mar 22. CTLT is higher by $0.01 from the previous closing price of $55.85 on volume of 660,850 shares. Over the past year the S&P 500 has risen 32.68% while CTLT is lower by -10.82%. CTLT lost -$7.18 per share the over the last 12 months. Click Here to get the full Stock Report for Catalent Inc stock.